)
Sai Life Sciences (SAILIFE) investor relations material
Sai Life Sciences Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved strong growth in Q2 FY26, maintaining positive momentum across discovery, development, and manufacturing services, supported by global client trust and scientific execution.
Investments in new modalities, advanced technologies, and capacity expansion are strengthening long-term competitiveness and scientific capabilities.
Focus remains on responsible scaling, technology-led innovation, and deepening client collaborations for sustainable growth.
Board approved unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2025, with statutory auditor review and unmodified conclusion.
Expanded into veterinary healthcare and enhanced end-to-end service capabilities through UK collaborations.
Financial highlights
H1 FY26 total revenue reached ₹10,338.89 million (INR 1,034 crores), up 53% year-over-year from ₹6,752.85 million in H1 FY25.
Q2 FY26 consolidated revenue was ₹5,374.70 million, up from ₹3,955.62 million in Q2 FY25; Q2FY26 EBITDA was ₹156 Cr with a 29% margin.
H1 FY26 EBITDA was ₹281 crores, a 101% increase from H1 FY25; EBITDA margin improved to 27.2%, up 652 bps year-over-year.
PAT for Q2 FY26 stood at ₹838.44 million, up from ₹415.10 million in Q2 FY25; H1 FY26 PAT was ₹1,442.99 million.
CapEx for H1 FY26 was ₹248 crores, focused on R&D infrastructure and new modalities.
Outlook and guidance
Capacity expansion on track, aiming to increase installed capacity from 700 KL to 1,150 KL by FY27.
Positioned to achieve 15–20% revenue CAGR over 3–5 years and 28–30% EBITDA margins in the next 2–3 years.
CapEx strategy prioritizes scalable infrastructure and technology depth, with a focus on asset productivity and margin improvement.
No specific guidance on gross margins, but EBITDA margin guidance remains at 28–30%.
Management and auditors confirm compliance with accounting standards and regulatory requirements, with no material misstatements identified.
Next Sai Life Sciences earnings date
Next Sai Life Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage